<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8211617</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6714</journal-id>
<journal-id journal-id-type="nlm-ta">Prog Neuropsychopharmacol Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Prog. Neuropsychopharmacol. Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Progress in neuro-psychopharmacology &amp; biological psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0278-5846</issn>
<issn pub-type="epub">1878-4216</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28989099</article-id>
<article-id pub-id-type="pmc">5889368</article-id>
<article-id pub-id-type="doi">10.1016/j.pnpbp.2017.10.002</article-id>
<article-id pub-id-type="manuscript">NIHMS919630</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Astroglial correlates of neuropsychiatric disease: from Astrocytopathy to Astrogliosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Ronald</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Healey</surname>
<given-names>Kati L.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sepulveda-Orengo</surname>
<given-names>Marian T.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reissner</surname>
<given-names>Kathryn J.</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<aff id="A1">Department of Psychology and Neuroscience, CB 3270, UNC Chapel Hill, Chapel Hill, NC, 27599</aff>
</contrib-group>
<author-notes>
<corresp id="FN1">Address correspondence to: Kathryn J. Reissner. Ph: +1 919-843-9112, <email>reissner@unc.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>20</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>20</day>
<month>12</month>
<year>2019</year>
</pub-date>
<volume>87</volume>
<issue>Pt A</issue>
<fpage>126</fpage>
<lpage>146</lpage>
<!--elocation-id from pubmed: 10.1016/j.pnpbp.2017.10.002-->
<abstract>
<p id="P1">Complex roles for astrocytes in health and disease continue to emerge, highlighting this class of cells as integral to function and dysfunction of the nervous system. In particular, escalating evidence strongly implicates a range of changes in astrocyte structure and function associated with neuropsychiatric diseases including major depressive disorder, schizophrenia, and addiction. These changes can range from astrocytopathy, degeneration, and loss of function, to astrogliosis and hypertrophy, and can be either adaptive or maladaptive. Evidence from the literature indicates a myriad of changes observed in astrocytes from both human postmortem studies as well as preclinical animal models, including changes in expression of glial fibrillary protein, as well as changes in astrocyte morphology and astrocyte-mediated regulation of synaptic function. In this review, we seek to provide a comprehensive assessment of these findings and consequently evidence for common themes regarding adaptations in astrocytes associated with neuropsychiatric disease. While results are mixed across conditions and models, general findings indicate decreased astrocyte cellular features and gene expression in depression, chronic stress and anxiety, but increased inflammation in schizophrenia. Changes also vary widely in response to different drugs of abuse, with evidence reflective of features of astrocytopathy to astrogliosis, varying across drug classes, route of administration and length of withdrawal.</p>
</abstract>
<kwd-group>
<kwd>astrocyte</kwd>
<kwd>GFAP</kwd>
<kwd>depression</kwd>
<kwd>schizophrenia</kwd>
<kwd>addiction</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>